Stock Report

All about this stock under one free report Last Updated: 09-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Sun Pharmaceutical Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SUNPHARMA | BSE: 524715

₹1,760.00

up-down-arrow ₹0.20 (0.01%)

As on 09-Oct-2026IST

Market cap

info icon

₹4,23,099 Cr

Revenue (TTM)

info icon

₹59,911 Cr

P/E Ratio

info icon

35

P/B Ratio

info icon

4.9

Div. Yield

info icon

0.9 %

Edit peer-selector-edit
Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Market cap (₹ Cr)
 4,23,099 1,76,354 1,05,573 1,11,641 98,292
Revenue (₹ Cr)
 59,911 15,723 28,324 28,592 14,738
Net Profit (₹ Cr)
 12,172.70 2,156.00 3,364.84 4,492.20 2,055.11
Net Margin (%)
 19.41 13.77 11.54 14.92 13.64
RoE (%)
 15.65 26.88 10.63 18.78 13.60
Price to Earnings
 34.98 80.86 31.32 24.74 48.12
Price-To-Book
 4.89 19.65 3.00 4.14 5.84

Income Statement (₹ Cr)

Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Operating Revenue arrow
59,910.52 15,723.00 28,324.40 28,591.70 14,737.88
Total Income arrow
62,725.79 15,654.00 29,158.75 30,111.40 15,061.79
Total Expenditure arrow
42,647.50 10,532.00 22,985.32 21,334.70 10,911.05
EBITDA arrow
17,263.02 5,191.00 5,339.08 7,257.00 3,826.83
Depreciation arrow
2,976.02 1,511.00 1,304.52 1,724.60 893.20
EBIT arrow
14,287.00 3,680.00 4,034.56 5,532.40 2,933.63
Interest arrow
363.78 634.00 57.37 510.20 578.61
Other Income arrow
2,815.27 -69.00 834.35 1,519.70 323.91
Exceptional Items arrow
-693.57 -110.00 -275.91 -534.80 -129.75
Profit before Tax arrow
16,044.92 2,867.00 4,535.63 6,007.10 2,549.18
Provision for Tax arrow
3,872.22 711.00 1,170.79 1,514.90 494.07
Profit after Tax arrow
12,172.70 2,156.00 3,364.84 4,492.20 2,055.11

Liabilities (₹ Cr)

Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Shareholder's Funds arrow
83,570.09 8,389.00 34,431.95 27,111.40 16,300.34
Minority Interest arrow
-21.43 25.00 14.98 -79.70 -24.90
Non-Current Liabilities arrow
2,283.44 18,384.00 962.15 7,112.50 5,011.23
Current Liabilities arrow
22,622.04 8,343.00 7,013.59 15,711.90 6,507.25
Total Liabilities arrow
1,08,407.20 43,613.69 42,342.71 50,672.60 27,754.83

Assets (₹ Cr)

Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Non-Current Assets arrow
43,711.29 33,955.00 15,471.21 31,677.20 20,274.65
Current Assets arrow
63,860.29 9,392.00 24,145.86 19,906.10 6,954.20
Total Assets arrow
1,08,407.20 43,613.69 42,342.71 50,672.60 27,754.83
Total Debt* arrow
4,081.61 14,798.24 257.97 11,769.50 6,021.78
Net Current Assets arrow
41,238.25 1,049.00 17,132.27 4,194.20 446.95
Contingent Liabilities arrow
1,587.05 379.25 987.37 989.90 924.77

Cashflow (₹ Cr)

Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Cash From Operating Activities arrow
12,419.18 3,022.71 3,940.02 2,116.60 3,121.29
Cash Flow from Investing Activities arrow
-11,344.05 -12,712.41 -2,326.13 -8,296.10 -196.42
Cash from Financing Activities arrow
-2,512.55 10,150.60 -1,233.65 5,806.90 -2,952.69
Net Cash Inflow / Outflow arrow
-1,437.42 460.90 380.24 -372.60 -27.82

Ratios

Profitability Ratios

 Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
ROCE (%) arrow
19.11 19.27 16.00 21.39 13.24
ROE (%) arrow
15.65 26.88 10.63 18.78 13.60
ROA (%) arrow
12.12 7.27 8.42 10.03 7.36
EBIT Margin (%) arrow
23.85 23.41 14.24 19.35 19.91
Net Margin (%) arrow
19.41 13.77 11.54 14.92 13.64
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Revenue Growth (%) arrow
11.41 32.85 1.85 21.11 14.16
EBIT Growth (%) arrow
8.10 20.66 -33.61 -8.99 19.45
Net Profit Growth (%) arrow
16.92 7.69 -37.77 -3.14 8.09
EPS Growth (%) arrow
10.18 12.04 -33.63 4.31 12.27
Book Value Growth (%) arrow
15.72 10.51 10.59 13.19 13.74

Valuation Ratios

 Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Price / Earnings arrow
33.29 69.91 29.45 22.76 46.09
Price / Book Value arrow
4.86 19.81 3.00 4.13 5.89
Dividend Yield (%) arrow
0.91 0.81 1.00 0.09 0.04
EV/EBITDA arrow
22.71 36.72 18.11 15.96 26.93
Market Cap (₹ Cr) arrow
4,21,639.92 1,42,851.87 98,797.18 87,643.18 82,801.75

Solvency Ratios

 Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Debt to Equity arrow
0.00 1.39 0.00 0.12 0.17
Short term debt to equity ratio arrow
0.05 0.35 0.00 0.16 0.04
Current Ratio arrow
2.82 1.13 3.44 1.27 1.07
Quick Ratio arrow
2.31 0.75 2.50 0.91 0.74
Interest Coverage arrow
45.11 5.52 80.06 12.77 5.41

Operating Efficiency Ratios

 Sun Pharmaceutical Torrent Pharma Cipla Zydus Lifesciences Mankind Pharma
Debtors to sales (%) arrow
25.89 19.28 19.84 18.94 11.74
Asset Turnover arrow
0.60 0.53 0.71 0.64 0.53
Receivable days arrow
89.14 45.41 52.05 33.55 39.93
Inventory Days arrow
67.85 52.67 57.25 33.80 51.78
Payable days arrow
213.72 244.06 115.96 149.82 111.46
Cash Conversion Cycle arrow
-56.72 -145.98 -6.65 -82.46 -19.75
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...